Adial Pharmaceuticals, Inc.ADILNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank44
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P44
Within normal range
vs 2Y Ago
-0.5x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2024-20.27%
202336.57%
202243.70%
2021-76.51%
2020-32.54%
2019-18.00%
2018-602.03%
2017-142.28%
201649.86%
20150.00%